Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011851
Filing Date
2021-05-12
Accepted
2021-05-12 17:00:51
Documents
76
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20210331_10q.htm 10-Q 631583
2 EXHIBIT 31.1 ex_247961.htm EX-31.1 9168
3 EXHIBIT 31.2 ex_247962.htm EX-31.2 9239
4 EXHIBIT 32.1 ex_247963.htm EX-32.1 6129
5 EXHIBIT 32.2 ex_247964.htm EX-32.2 6341
  Complete submission text file 0001437749-21-011851.txt   4699715

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cenb-20210331.xml EX-101.INS 881457
7 XBRL TAXONOMY EXTENSION SCHEMA cenb-20210331.xsd EX-101.SCH 68762
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20210331_cal.xml EX-101.CAL 31435
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20210331_def.xml EX-101.DEF 434214
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20210331_lab.xml EX-101.LAB 324052
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20210331_pre.xml EX-101.PRE 457568
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 21915943
SIC: 2834 Pharmaceutical Preparations